Boothbay Fund Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $881K | Sell |
40,591
-14,292
| -26% | -$310K | 0.02% | 562 |
|
|
2025
Q1 | $1.33M | Sell |
54,883
-21,982
| -29% | -$533K | 0.04% | 423 |
|
|
2024
Q4 | $1.6M | Sell |
76,865
-29,362
| -28% | -$613K | 0.04% | 415 |
|
|
2024
Q3 | $2.11M | Sell |
106,227
-14,623
| -12% | -$291K | 0.05% | 413 |
|
|
2024
Q2 | $1.87M | Hold |
120,850
| – | – | 0.04% | 439 |
|
|
2024
Q1 | $1.93M | Buy |
120,850
+12,524
| +12% | +$200K | 0.04% | 439 |
|
|
2023
Q4 | $1.82M | Hold |
108,326
| – | – | 0.05% | 436 |
|
|
2023
Q3 | $1.27M | Buy |
+108,326
| New | +$1.27M | 0.03% | 544 |
|
|
2018
Q4 | – | Sell |
-100,181
| Closed | -$379K | – | 615 |
|
|
2018
Q3 | $379K | Buy |
100,181
+16,000
| +19% | +$60.5K | 0.04% | 344 |
|
|
2018
Q2 | $263K | Sell |
84,181
-38,819
| -32% | -$121K | 0.02% | 402 |
|
|
2018
Q1 | $294K | Buy |
+123,000
| New | +$294K | 0.03% | 373 |
|
|
2017
Q3 | – | Sell |
-68,970
| Closed | -$190K | – | 541 |
|
|
2017
Q2 | $190K | Sell |
68,970
-66,902
| -49% | -$184K | 0.04% | 490 |
|
|
2017
Q1 | $265K | Buy |
+135,872
| New | +$265K | 0.05% | 397 |
|
|
2016
Q1 | – | Sell |
-39,695
| Closed | -$97K | – | 316 |
|
|
2015
Q4 | $97K | Sell |
39,695
-23,972
| -38% | -$58.6K | 0.04% | 468 |
|
|
2015
Q3 | $191K | Buy |
+63,667
| New | +$191K | 0.09% | 314 |
|